In compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Hester Biosciences has submitted a copy of the published extract of consolidated unaudited financial results for the quarter ended 30 June 2023 along with information on standalone financial results. The same was published on Wednesday, 9 August 2023 in the Ahmedabad edition of Financial Express (English) and Financial Express (Gujarati).
The above information is a part of company’s filings submitted to BSE.
